The present study was designed to compare the effects and duration of rapid filling, improved in both treatment groups to the same extent. However, systolic performof angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists -the two drug classes thought to ance, as assessed by midwall fractional fibre shortening, was significantly improved by ACE inhibitors only. be most effective in reducing left ventricular hypertrophy -on arterial pressure, left ventricular structure and Myocardial contractility (end-systolic wall stress/endsystolic volume index) showed no significant change in function in patients with essential hypertension.
Introduction
most effective in reducing LVH -on arterial blood Left ventricular hypertrophy (LVH), a common pressure (BP), left ventricular structure and left venfinding in patients with essential hypertension, has tricular performance in patients with essential been identified as a powerful risk factor for cardiohypertension. vascular morbidity and mortality.
1-3 However, the effect of LVH on systolic left ventricular function is
Subjects and methods
controversial, with some studies suggesting increased systolic function in the presence of LVH 4, 5 Subjects and others reporting depressed systolic left ventricular performance when midwall fractional fibre short-
The study population consisted of 96 patients with ening is used as a marker of systolic function. [6] [7] [8] established stage I or stage II essential hypertension. Although, by definition, all antihypertensive Secondary causes of arterial hypertension were drugs lower arterial pressure, their effect on left venruled out by routine clinical and laboratory examintricular mass is not well established. Most studies ations and none of the patients had a history of myoinvestigating the effect of antihypertensive therapy cardial infarction or cerebrovascular accident. Some on left ventricular mass are small and non-comparaof the patients had never been treated, and for those tive, and although several meta-analyses have been who had been, all antihypertensive medication was performed, 9-11 this type of evaluation has its own discontinued at least 4 weeks before study entry. inherent limitations and does not provide any data During the last 4 weeks before active treatment, all on left ventricular function after reduction of LVH.
patients were treated with placebo. Patients were Therefore, we compared the effect of calcium antagincluded in the study only if they had a diastolic BP onists and angiotensin-converting enzyme (ACE) (DBP) (phase 5 of Korotkoff) of у90 mm Hg on the last two visits before starting active therapy, and a baseline echocardiogram of acceptable quality. Pre- arterial BP to the same extent, but the heart rate or fosinopril), and 50 patients were treated with one remained essentially unchanged in both groups of six different calcium antagonists (verapamil, ( Table 2) . gallopamil, diltiazem, nifedipine, nitrendipine, isradipine). Patients fulfilling the inclusion criteria were assigned to a specific antihypertensive drug in Left ventricular structure blocks of seven to nine patients. BP response was
The echocardiographic findings before and after assessed every 2 weeks. If the therapeutic goal antihypertensive treatment in the two groups are (diastolic pressure Ͻ90 mm Hg) was still not summarised in Table 3 . When compared with calachieved, doses were gradually increased until the cium antagonists, ACE inhibitors had a more prohighest recommended dose for each individual drug nounced effect on posterior and septal wall thickwas reached. After 12 weeks of therapy, all ness, whereas no significant differences were seen haemodynamic, echocardiographic, and laboratory in left ventricular internal dimensions. Therefore, studies were repeated.
while both treatment groups significantly reduced left ventricular mass index (LVMI), ACE inhibitors had a significantly greater effect on LVMI than calEchocardiographic studies cium antagonists. In fact, the decrease in LVMI with By study design, all patients had echocardiographic ACE inhibition was almost twice as high compared tracings of acceptable quality before and after antiwith calcium antagonists (13% vs 7%, Figure 1 ). hypertensive therapy. Patients were studied in the Since baseline LVMI was slightly higher in the partial left decubitus position, and left ventricular group treated with ACE inhibitors and a significant echocardiograms were obtained in the standard correlation existed between baseline LVMI and manner at or just below the tips of the mitral valve change of LVMI with therapy (r = 0.23; P: 0.03), leaflets with the transducer applied in the third or ANCOVA was used to adjust for these differences. fourth intercostal space. Left ventricular posterior wall thickness, septal wall thickness, and systolic Left ventricular function and diastolic dimensions were measured using the Penn convention.
12 Each echocardiographic tracing As shown in Table 3 , diastolic function, as measwas coded and read in a blinded manner by two ured by peak filling rate and duration of rapid filling, investigators. Left ventricular mass was calculated markedly improved in both treatment groups; howaccording to the formula of Devereux and Reichek. 12 ever, no significant differences between ACE inhibiSystolic left ventricular function was estimated by tor and calcium antagonist treatment were noted. calculating ejection fraction, endocardial fractional
When systolic left ventricular function was evalufibre shortening, midwall fractional fibre shortening, ated according to the standard parameters measured and the percentage of predicted midwall fibre shortat the endocardium (fractional fibre shortening, ejecening according to meridional end-systolic wall tion fraction), none of the treatment groups showed stress.
8 Myocardial contractility was determined by a significant change with treatment. However, when the ratio of end-systolic wall stress to end-systolic midwall fractional fibre shortening was used to volume index.
13,14 Diastolic function was deterevaluate systolic performance, taking into account mined with computer assistance as described by the epicardial migration of the midwall during sysUpton and Gibson. 15 Septal and posterior wall endotole, treatment with ACE inhibitors improved syscardial echoes were digitised, and continuous plots tolic performance (P Ͻ 0.05), whereas no significant were made of left ventricular minor axis dimension change was observed with calcium antagonists vs time and the rate of change of dimension vs time.
( Table 3 ), leading to a significant difference between For each patient, three to five consecutive cycles the two treatment groups (Figure 1 ). The ratio of were analysed and averaged. The peak filling rate of end-systolic wall stress to end-systolic volume the left ventricle and the duration of rapid filling index as a load-independent index for myocardial represent the diastolic function. An increase in peak filling rate or a decrease in duration of rapid filling are expressed as mean ± standard deviation. ) 118 ± 14 105 ± 15** −11 116 ± 12 103 ± 9** −11 HR (bpm) 69 ± 11 67 ± 11 −3 6 8 ± 9 6 9 ± 10 −1.5
Data are expressed as mean ± standard deviation. **P Ͻ 0.001 vs baseline. SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure; HR = heart rate. PWT = posterior wall thickness; SWT = septal wall thickness; LVD = left ventricular internal diameter; LVMI = left ventricular mass index; PFR = peak filling rate; DRF duration of rapid filling; eFFS = endocardial fractional fibre shortening; mFFS = midwall fractional fibre shortening; %pred mFFS = per cent of predicted mFFS according to meridional end-systolic wall stress; ESWS/ESVI = end-systolic wall stress/end-systolic volume index. *P Ͻ 0.05 vs baseline; **P Ͻ 0.001 vs baseline; †P Ͻ 0.05 vs calcium antagonists.
effect on arterial BP, they show disparate effects on left ventricular structure and function. Compared with calcium antagonists, ACE inhibitors had a significantly greater effect on regression of left ventricular mass, which was caused by a more pronounced decrease in septal and posterior wall thickness. Left ventricular internal dimensions remained unaltered in both treatment groups. These findings suggest that regression of left ventricular mass in treated hypertensives may be at least in part a drug class-specific effect rather than solely dependent on reduction of arterial BP.
Which properties of ACE inhibitors may be responsible for its superior efficacy in reducing system may play a major role in the development of cardiac hypertrophy through direct stimulation of cardiac myocytes and non-myocytes by angiotensin contractility showed no significant changes after II. 16, 17 As a consequence, blockage of cardiac angiotreatment with ACE inhibitors, whereas after treattensin II by ACE inhibitors may contribute, indement with calcium antagonists, a significant pendent of BP, to the reversal of myocardial decrease in myocardial contractility was observed.
hypertrophy. Another important effect of ACE Since the baseline indices of systolic function were inhibitors is the inhibition of bradykinin degrasignificantly different in the two treatment groups, dation. This peptide hormone has been shown to ANCOVA was used for comparisons between groups partially mediate the acute and chronic antihyperto adjust for these differences.
tensive actions of ACE inhibitors, 18 but it may also play a role in the prevention of cardiac hypertrophy.
Discussion
Indeed, it could be demonstrated that the bradykinin receptor antagonist icatibant blunted the The present study suggests that while ACE inhibitors and calcium antagonists have a very similar prevention of cardiac hypertrophy by ramipril in tors is associated with a small but significant end-systolic wall stress to end-systolic volume
